Alemtuzumab containing reduced intensity conditioning regimen is safe and effective in myelofibrosis.

W A Ingram, A Y L Ho, M Kenyon, S Devereux, A Pagliuca, G Mufti

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	5465
Number of pages	1
Journal	Blood
Volume	102
Issue number	11
Publication status	Published - 2003
Event	45th Annual Meeting of the American-Society-of-Hematology - SAN DIEGO, CALIFORNIA Duration: 1 Jan 2003 → …

Cite this

@article{328189825a7b40cea1d6e3eb661a8924,

title = "Alemtuzumab containing reduced intensity conditioning regimen is safe and effective in myelofibrosis.",

author = "Ingram, {W A} and Ho, {A Y L} and M Kenyon and S Devereux and A Pagliuca and G Mufti",

year = "2003",

language = "English",

volume = "102",

pages = "5465",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

number = "11",

note = "45th Annual Meeting of the American-Society-of-Hematology ; Conference date: 01-01-2003",

}

TY - JOUR

T1 - Alemtuzumab containing reduced intensity conditioning regimen is safe and effective in myelofibrosis.

AU - Ingram, W A

AU - Ho, A Y L

AU - Kenyon, M

AU - Devereux, S

AU - Pagliuca, A

AU - Mufti, G

PY - 2003

Y1 - 2003

M3 - Meeting abstract

SN - 1528-0020

VL - 102

SP - 5465

JO - Blood

JF - Blood

IS - 11

T2 - 45th Annual Meeting of the American-Society-of-Hematology

Y2 - 1 January 2003

ER -